The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abnormalities of the Extracellular Degradation of Collagen Type I in Essential Hypertension
Abstract
Background —This study was designed to investigate whether collagen type I degradation is altered in patients with essential hypertension and whether this alteration could be related to disturbances in the serum matrix metalloproteinase pathway of collagen degradation. A second aim of the study was to assess whether some relation exists between serum markers of collagen type I degradation and left ventricular hypertrophy in hypertensive patients. Methods and Results —We measured serum concentrations of carboxy-terminal telopeptide of collagen type I (CITP) as a marker of extracellular collagen type I degradation, of total matrix metalloproteinase-1 (MMP-1), or collagenase, of total tissue inhibitor of metalloproteinases 1 (TIMP-1), and of MMP-1/TIMP-1 complex in 37 patients with never-treated essential hypertension and in 23 normotensive control subjects. Serum concentrations of free MMP-1 and free TIMP-1 were calculated by subtracting the values of MMP-1/TIMP-1 complex from the values of total MMP-1 and total TIMP-1, respectively. Measurements were repeated in 26 hypertensive patients after 1 year of treatment with the ACE inhibitor lisinopril. Baseline free MMP-1 was decreased ( P <0.001) and baseline free TIMP-1 was increased ( P <0.001) in hypertensives compared with normotensives. No significant differences were observed in the baseline values of CITP between the 2 groups of subjects. Hypertensive patients with baseline left ventricular hypertrophy exhibited lower values of free MMP-1 ( P <0.01) and CITP ( P <0.05) and higher ( P <0.001) values of free TIMP-1 than hypertensive patients without baseline left ventricular hypertrophy. Treated patients attained an increase ( P <0.001) in free MMP-1 and a decrease ( P <0.05) in free TIMP-1. In addition, serum CITP was increased ( P <0.05) in treated hypertensives compared with normotensive subjects. Conclusions —These findings suggest that systemic extracellular degradation of collagen type I is depressed in patients with essential hypertension and can be normalized by treatment with lisinopril. A depressed degradation of collagen type I may facilitate organ fibrosis in hypertensive patients, namely, in those with left ventricular hypertrophy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.
Devereux, R. B., & Reichek, N. (1977) · Circulation · doi:10.1161/01.cir.55.4.613 · Cited by 4,485
Matrix metalloproteinases and their inhibitors in connective tissue remodeling
Woessner, J. F. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.8.1850705 · Cited by 3,282
Transforming Growth Factor β in Tissue Fibrosis
Epstein, F. H., Border, W. A., & Noble, N. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311907 · Cited by 3,069
Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension
Ganau, A., Devereux, R. B., Roman, M. J., de Simone, G., Pickering, T. G., Saba, P. S., Vargiu, P., Simongini, I., & Laragh, J. H. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90617-v · Cited by 1,605
Cell Biology of Extracellular Matrix
(1988) · Springer eBooks · doi:10.1007/978-1-4613-0881-2 · Cited by 1,470
Edwards, D. R., Murphy, G., Reynolds, J. J., Whitham, S. E., Docherty, A. J., Angel, P., & Heath, J. K. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02449.x · Cited by 1,221
Matrix Metalloproteinases and Cardiovascular Disease
Dollery, C. M., McEwan, J. R., & Henney, A. M. (1995) · Circulation Research · doi:10.1161/01.res.77.5.863 · Cited by 864
NISHIMURA, R. A., ABEL, M. D., HATLE, L. K., & TAJIK, A. J. (1989) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65673-0 · Cited by 752
Naftilan, A. J., Pratt, R. E., & Dzau, V. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114032 · Cited by 623
Risteli, J., Elomaa, I., Niemi, S., Novamo, A., & Risteli, L. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.4.635 · Cited by 622
Cited by
Vascular Remodeling in Hypertension: Roles of Apoptosis, Inflammation, and Fibrosis
Intengan, H. D., & Schiffrin, E. L. (2001) · Hypertension · doi:10.1161/hy09t1.096249 · Cited by 979
Zannad, F., Alla, F., Dousset, B., Perez, A., & Pitt, B. (2000) · Circulation · doi:10.1161/01.cir.102.22.2700 · Cited by 947
ECM remodeling in hypertensive heart disease
Berk, B. C., Fujiwara, K., & Lehoux, S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31044 · Cited by 902
Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease
Fan, D., Takawale, A., Lee, J., & Kassiri, Z. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-15 · Cited by 814
Aldosterone in Congestive Heart Failure
Weber, K. T. (2001) · New England Journal of Medicine · doi:10.1056/nejmra000050 · Cited by 770
Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease
Raffetto, J. D., & Khalil, R. A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.004 · Cited by 752
Díez, J., Querejeta, R., López, B., González, A., Larman, M., & Martínez Ubago, J. L. (2002) · Circulation · doi:10.1161/01.cir.0000017264.66561.3d · Cited by 637
Self-citationYasmin, Wallace, S., McEniery, C. M., Dakham, Z., Pusalkar, P., Maki-Petaja, K., Ashby, M. J., Cockcroft, J. R., & Wilkinson, I. B. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000151373.33830.41 · Cited by 501
Regulation of Collagen I and Collagen III in Tissue Injury and Regeneration
Singh, D., Rai, V., & K Agrawal, D. (2023) · Cardiology and Cardiovascular Medicine · doi:10.26502/fccm.92920302 · Cited by 461
Intengan, H. D., & Schiffrin, E. L. (2000) · Hypertension · doi:10.1161/01.hyp.36.3.312 · Cited by 459
Ahmed, S. H., Clark, L. L., Pennington, W. R., Webb, C. S., Bonnema, D. D., Leonardi, A. H., McClure, C. D., Spinale, F. G., & Zile, M. R. (2006) · Circulation · doi:10.1161/circulationaha.105.573865 · Cited by 386
Jacob, M. P. (2003) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(03)00065-9 · Cited by 368
Querejeta, R., Varo, N., López, B., Larman, M., Artiñano, E., Etayo, J. C., Ubago, J. L. M., Gutierrez-Stampa, M., Emparanza, J. I., Gil, M. J., et al. (2000) · Circulation · doi:10.1161/01.cir.101.14.1729 · Cited by 368
Self-citationKasner, M., Westermann, D., Lopez, B., Gaub, R., Escher, F., Kühl, U., Schultheiss, H.-P., & Tschöpe, C. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.10.024 · Cited by 328
SCHIFFRIN, E. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.05.023 · Cited by 327
Brain Natriuretic Peptide Is Produced in Cardiac Fibroblasts and Induces Matrix Metalloproteinases
Tsuruda, T., Boerrigter, G., Huntley, B. K., Noser, J. A., Cataliotti, A., Costello-Boerrigter, L. C., Chen, H. H., & Burnett, J. C. (2002) · Circulation Research · doi:10.1161/01.res.0000046234.73401.70 · Cited by 301
Fibrosis and hypertensive heart disease
Weber, K. T. (2000) · Current Opinion in Cardiology · doi:10.1097/00001573-200007000-00010 · Cited by 300
Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers
Twigg, S. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s1991 · Cited by 286
Izawa, H., Murohara, T., Nagata, K., Isobe, S., Asano, H., Amano, T., Ichihara, S., Kato, T., Ohshima, S., Murase, Y., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.571653 · Cited by 268
Schiffrin, E. L., & Touyz, R. M. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00262.2004 · Cited by 253
Extracellular matrix alterations in hypertensive vascular remodeling
Lemarié, C. A., Tharaux, P.-L., & Lehoux, S. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.09.018 · Cited by 192
“Hypertensive patients with baseline left ventricular hypertrophy (LVH) exhibited lower MMP-1 and higher TIMP-1 than hypertensive patients without baseline LVH or normotensive subjects [17].”
BackgroundBiochemical evidence of myocardial fibrosis in veteran endurance athletes
Lindsay, M. M., & Dunn, F. G. (2007) · British Journal of Sports Medicine · doi:10.1136/bjsm.2006.031534 · Cited by 96
Correlation of first trimester placental volume and second trimester uterine artery Doppler flow
Hafner, E., Metzenbauer, M., Dillinger-Paller, B., Hoefinger, D., Schuchter, K., Sommer-Wagner, H., & Philipp, K. (2001) · Placenta · doi:10.1053/plac.2001.0721 · Cited by 65
Myocardial collagen turnover in normotensive obese patients: relation to insulin resistance
Quilliot, D., Alla, F., Böhme, P., Bruntz, J.-F., Hammadi, M., Dousset, B., Ziegler, O., & Zannad, F. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803022 · Cited by 61
Metadata
- Authors
- Laviades, C., Varo, N., Fernández, J., Mayor, G., Gil, M. J., Monreal, I., & Díez, J.
- Venue
- Circulation
- Published
- 1998-08-11
- Volume
- 98
- Issue
- 6
- Pages
- 535-540
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2105809486
- Cited by
- 298
- References
- 27
- FWCI
- 4.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.